Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biomemory specializes in sustainable molecular computing solutions, leveraging living cells to produce bio-sourced double-stranded DNA for ultra-dense, durable, and sustainable digital data storage. The company has demonstrated the viability of its DNA-based technology with a "DNA Drive" prototype and recently secured $18 million in Series A funding to further develop and commercialize its molecular data storage appliance. Founded in Paris in 2021 by scientists from Sorbonne Université, Biomemory targets enterprise, cloud, and data center customers, offering an innovative alternative to conventional electronic memory/storage media with minimal environmental impact. As a non-healthcare company, it has no clinical results.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biomemory.